Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Healthcare is failing Gen Z - New innovation offers potential 97% saving to NHS
LovedBy, the health technology and consultancy business, today announces the launch of ‘Nudg with Dexcom’ […]
LovedBy and Dexcom Announce Partnership to Help Adolescent Diabetes Patients
LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]
LovedBy Hires Former AXA Health Executive Arup Paul as Clinical Director
LovedBy, a technology and consultancy business that exists to improve the lives of people, their […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more